Back to updates

Essential drugs - November 2022 update

Select language:

This guide has been updated. This month's revision includes in particular: significant changes (17), new entries (0), deleted entries (0).

Significant changes
  • Oral drugs:
    • Abacavir: fully revised
    • Atazanavir: fully revised
    • Darunavir: fully revised
    • Dolutegravir: fully revised
    • Efavirenz: fully revised
    • Fluconazole: fully revised
    • Lamivudine: fully revised
    • Lopinavir/ritonavir: fully revised
    • Nevirapine: fully revised
    • Paracetamol: posology in patients with dengue or malnutrition added
    • Resomal: fully revised 
    • Ritonavir: fully revised
    • Tenofovir: fully revised
    • Zidovudine: fully revised

 

  • Injectable drugs:
    • Calcium gluconate: fully revised
    • Epinephrine: fully revised
    • Fluconazole: fully revised